Last Updated on March 22, 2025 by The Health Master
USFDA approval
The United States Food and Drug Administration approval (USFDA approval) has been granted to Zydus Lifesciences to manufacture and distribute Methenamine Hippurate Tablets USP, 1 gram.
The USFDA approval for the said drug is a generic version of Hiprex Tablets, 1 gram, offering a more accessible option for patients suffering recurrent urinary tract infections (UTIs).
Chronic UTI Management:
Methenamine Hippurate tablets play an important role in the treatment and therapy of frequently recurring UTIs.
This is particularly important for patients requiring long-term management to prevent persistent infections.
Indication:
- Long-term UTI prevention.
- Individuals with recurring UTIs.
- Reduces the burden of chronic infections.
Manufacturing:
The manufacturing of these tablets will be done at the manufacturing facility of Zydus Lifesciences Ltd (SEZ) situated in Ahmedabad, Gujarat, India.
Q: What is the use of Methenamine Hippurate?
A: Methenamine Hippurate is used for the prevention and suppression of frequently recurring urinary tract infections (UTIs).
Q: Where will the Methenamine Hippurate tablets be manufactured?
A: These tablets will be manufactured at the manufacturing facility of Zydus Lifesciences Ltd (SEZ), situated in Ahmedabad, Gujarat, India.
Q: What is an ANDA?
A: It is known as the Abbreviated New Drug Application (ANDA), which is filed with the USFDA for approval to market a generic drug that is bioequivalent to a brand-name drug.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Disclaimer: The information we have provided is for general knowledge and for informational purpose only and it cannot be treated as medical advice. Always consult your doctor for any health issues and / or for the treatment of the same. The Health Master does not claim responsibility for this information.
USFDA approval granted for Ketoconazole Shampoo, 2%
USFDA approval granted for first Nicotine Pouches
USFDA approval granted for this Genetic Disorder drug
USFDA approval granted for Latanoprost Ophthalmic Solution
USFDA approval granted for Sitagliptin and Metformin Hydrochloride Tablets
USFDA approval granted for Medical Device for heart condition
Himachal: 1471 NSQ drugs in past 2 years: Minister
DTAB: Drugs Technical Advisory Board reconstituted: Detail here
USFDA approval granted for Ketoconazole Shampoo, 2%
India: 11th in Global Pharma Exports with Quality and Transparency
CDSCO issues new Export NOC System: Details
West Bengal into action against counterfeit drugs in the state
USFDA inspection concluded at JB Chemicals and Pharma Gujarat
NSQ Drug: New Guidelines Proposed
Govt invites Pharma MedTech companies for funding: Apply now
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
